2021 pro consortium workshop - where are we headed with activity monitors in clinical trials?
Published 3 years ago • 95 plays • Length 1:34:14Download video MP4
Download video MP3
Similar videos
-
1:29:03
2021 pro consortium workshop: identifying coas for use in rare disease treatment trials
-
1:12:59
2021 pro consortium workshop - fda update
-
1:39:40
2021 pro consortium workshop - migraine: a tale of two paths to pro-based product labeling
-
18:40
2022 pro consortium workshop: welcome and patient-reported outcome consortium update
-
17:35
2021 pro consortium workshop - ecoa: getting better together initiative
-
1:36:07
2022 pro consortium workshop: session 3: using digital health technology to measure what matters
-
18:54
2022 pro consortium workshop: ecoa: getting better together initiative update
-
16:37
workshop - welcome and patient-reported outcome consortium update
-
1:25:46
biomarkers of effect webinar panel discussion
-
1:28:54
covid-19 mitigation strategies in pediatric rare disease clinical trials virtual workshop
-
55:46
cgic2024 day 3: patient-focused drug development in the age of cell and gene-based therapies
-
1:09:33
ecoa: getting better together initiative – update from c-path’s pro consortium and epro consortium
-
1:00:16
covid19:risk assessment, mitigation strategies for the collection of pro data through clinical sites
-
54:31
pkdoc: adaptive clinical trials - meg jardine presentation
-
2:16:47
2021 inc annual meeting | session iii | real-world data
-
45:00
clinical research connections
-
5:27
clinical trial project management
-
5:44
how to see critical path in ms project | critical path not showing ?